Fasanaro A, Paone G, Silvestri I, Marottoli V, Cimino R, Ferrara F
Division of Hematology, Cardarelli General Hospital, Naples, Italy.
Cancer Genet Cytogenet. 1994 Jul 15;75(2):106-10. doi: 10.1016/0165-4608(94)90160-0.
We describe a case of a patient affected by a chronic myeloproliferative disorder with t(8;21)(q22;q22) and trisomy 8 at diagnosis. At the time of blastic metamorphosis, 2 months later, trisomy 8 metaphases were significantly reduced, while a predominance of t(8;21) was present. Finally, in the phase of leukemic regrowth following chemotherapy administration, monosomy 8 associated with der(21)t(8;21) was the predominant cytogenetic abnormality.